Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Fatih, Güzelbulut"'
Publikováno v:
Revista da Associação Médica Brasileira, Volume: 68, Issue: 9, Pages: 1161-1165, Published: 07 OCT 2022
Revista da Associação Médica Brasileira v.68 n.9 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira v.68 n.9 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
SUMMARY OBJECTIVE: Hepatocellular carcinoma is the most common primary malignant liver tumor. Mitochondrial DNA copy number has been shown to be associated with various malignancies. However, there has not been any study on the absolute quantificatio
Autor:
Cumali Efe, Anand V. Kulkarni, Benedetta Terziroli Beretta‐Piccoli, Bianca Magro, Albert Stättermayer, Mustafa Cengiz, Daniel Clayton‐Chubb, Craig Lammert, Christine Bernsmeier, Özlem Gül, Fatima Higuera‐de la Tijera, Margarita Anders, Ellina Lytvyak, Mete Akın, Tugrul Purnak, Rodrigo Liberal, Mirta Peralta, Berat Ebik, Serkan Duman, Nurhan Demir, Yasemin Balaban, Álvaro Urzua, Fernando Contreras, Maria Grazia Venturelli, Yılmaz Bilgiç, Adriana Medina, Marcos Girala, Fulya Günşar, Maria‐Carlota Londoño, Theodoros Androutsakos, Ayelen Kisch, Alper Yurci, Fatih Güzelbulut, Yasir Furkan Çağın, Enver Avcı, Murat Akyıldız, Emine Kübra Dindar‐Demiray, Murat Harputluoğlu, Rahul Kumar, Sanjaya K. Satapathy, Manuel Mendizabal, Marcelo Silva, Stefano Fagiuoli, Stuart K. Roberts, Neşe Karadağ Soylu, Ramazan Idilman, Eric M. Yoshida, Aldo J. Montano‐Loza, George N. Dalekos, Ezequiel Ridruejo, Thomas D. Schiano, Staffan Wahlin
Publikováno v:
Hepatology. 76:1576-1586
© 2022 American Association for the Study of Liver Diseases.Background and Aims: A few case reports of autoimmune hepatitis–like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We eva
Autor:
Kamil Ozdil, Fatih Güzelbulut, Pınar Gökçen, Güray Can, Gupse Adali, Özgür Bahadır, Ayça Gökçen Değirmenci Saltürk, Hamdi Levent Doganay
Publikováno v:
Journal of Viral Hepatitis. 28:826-836
The HCC-RESCUE score was developed to predict hepatocellular carcinoma (HCC) risk in Korean chronic hepatitis B (CHB) patients under entecavir therapy. We aimed to validate the HCC-RESCUE score to predict HCC risk in Caucasian CHB patients under ente
Autor:
Mevlut Kiyak, Serhat Özer, Özgür Bahadır, Halil Sahin, Cüneyt Saltürk, Fatih Güzelbulut, Ayça Gökçen Değirmenci Saltürk, Emine Kanatsiz
Publikováno v:
Viral Hepatitis Journal. 26:119-123
Autor:
Muhammed Kaya, Esra Yeşilyurt, Hayrünnisa Sezikli, Mesut Sezikli, Fatih Güzelbulut, Göktuğ Şirin, Seyyid Bilal Acikgoz, Gökhan Dindar
Publikováno v:
Viral Hepatitis Journal. 26:69-73
Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) levels in patients with chronic hep
Autor:
George N. Dalekos, Cristina Rigamonti, Godolfino Miranda Zazueta, Ali Rıza Calışkan, Annarosa Floreani, Berat Ebik, Kadri Atay, Aylin Demirezer Bolat, Nazım Ekin, Eric M. Yoshida, Graciela Castro Narro, Fatih Güzelbulut, Murat Biyik, Manuel Mendizabal, Renumathy Dhanasekaran, Stefano Fagiuoli, Thomas D. Schiano, Ellina Lytvyak, Shalom Frager, Nataly Chris Escajadillo Vargas, Yucel Ustundag, Ramazan Idilman, Andreea M. Catana, Alvaro Urzúa, Ahmet Yavuz, Staffan Wahlin, Mesut Aydin, Cumali Efe, Laura Cristoferi, Hatef Massoumi, Maria Vincent, Sandro Ruiz Garcia, Evrim Kahramanoğlu-Aksoy, Natalia Ratusnu, Craig Lammert, Sümeyra Yıldırım, Mário Reis Álvares-da-Silva, Murat Harputoğlu, Marina Silveira, Murat Kiyici, Fátima Higuera-de la Tijera, Nurhan Demir, Cynthia Levy, Einar Bjornsson, Javier Brahm, Rotonya M. Carr, Nidah S. Khakoo, Andres Jose Gomez Aldana, Murat Akyildiz, Leyla Nazal, Alessio Gerussi, Tuğçe Eşkazan, Zeynep Ellik, Pietro Invernizzi, Fulya Gunsar, Ezequiel Ridruejo, Eleonora De Martin, Tugrul Purnak, Fatih Eren, Hüseyin Kaçmaz, Margarita Anders, Nikolaos K. Gatselis, Romee Snijders, Sezgin Barutçu, Costica Aloman, Alexandra Heurgue-Berlot, Bianca Magro, Jonathan Aguirre, Kader Irak, Koray Tascilar, Aldo J. Montano-Loza, Marcelo Silva, David N. Assis, Joost P.H. Drenth, Eira Cerda Reyes, Ibrahim Hatemi, Mirta Peralta, Sanjaya K. Satapathy, James L. Boyer, Yasemin H. Balaban
Publikováno v:
Liver International, 42, 607-614
Liver International
Liver International, 42, 3, pp. 607-614
Liver International
Liver International, 42, 3, pp. 607-614
Background We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods Data of AIH patients with laboratory confirmed COVID-19 we
Autor:
Cumali Efe, Koray Taşçılar, Alessio Gerussi, Francesca Bolis, Craig Lammert, Berat Ebik, Albert Friedrich Stättermayer, Mustafa Cengiz, Dilara Turan Gökçe, Laura Cristoferi, Mirta Peralta, Hatef Massoumi, Pedro Montes, Eira Cerda, Cristina Rigamonti, Suna Yapalı, Gupse Adali, Ali Rıza Çalışkan, Yasemin Balaban, Fatih Eren, Tuğçe Eşkazan, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Meral Akdogan Kayhan, Alexandra Heurgue-Berlot, Eleonora De Martin, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Serkan Duman, Nelia Hernandez, Nikolaos K. Gatselis, Jonathan Aguirre, Ramazan Idilman, Marcelo Silva, Manuel Mendizabal, Kadri Atay, Fatih Güzelbulut, Renumathy Dhanasekaran, Aldo J. Montano-Loza, George N. Dalekos, Ezequiel Ridruejo, Pietro Invernizzi, Staffan Wahlin
Publikováno v:
Journal of Autoimmunity. 132:102906
Background: Data regarding outcome of Coronavirus disease 2019 (COVID-19) in vaccinated patients with autoimmune hepatitis (AIH) are lacking. We evaluated the outcome of COVID-19 in AIH patients who received at least one dose of Pfizer- BioNTech (BNT
Autor:
Züleyha Akkan Çetinkaya, Hayrünnisa Sezikli, Fatih Güzelbulut, Efe Serkan Boz, Alpaslan Tanoglu, Muhammed Kaya, Mesut Sezikli
In this study, we aimed to evaluate the effects of vitamins C and E onHelicobacter pyloriin vitro, in other words in the absence of the in vivo dynamics of the gastric mucosa. The study included 32 patients withH. pylori-positive nonulcer dyspepsia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8c1bad40c081b77c274005157ea7b8
https://zenodo.org/record/5218982
https://zenodo.org/record/5218982
Autor:
Hamdi Levent Doganay, Gupse Adali, Fatih Güzelbulut, Ekrem Aslan, Kamil Ozdil, Ayça Gökçen Değirmenci Saltürk, Güray Can, Pınar Gökçen
Publikováno v:
Turk J Gastroenterol
Background: It is controversial whether entecavir or tenofovir differs in reducing hepatocellular carcinoma (HCC) risk. We aimed to compare the efficacy of entecavir and tenofovir in reducing HCC risk in chronic hepatitis B (CHB) patients. Methods: T
Autor:
Kamil Ozdil, Levent Doganay, Gupse Adali, Fatih Güzelbulut, Pınar Gökçen, Büşra Ünal, Ayça Gökçen Değirmenci Saltürk, Nihat Bugra Agaoglu
Publikováno v:
Hepatology Forum.